{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T17:47:50Z","timestamp":1696528070568},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s12272-001-2121-2","type":"journal-article","created":{"date-parts":[[2008,11,20]],"date-time":"2008-11-20T14:01:59Z","timestamp":1227189719000},"page":"1385-1392","source":"Crossref","is-referenced-by-count":6,"title":["Enhancement of the immune responses of mice to Bacillus anthracis protective antigen by CIA07 combined with alum"],"prefix":"10.1007","volume":"31","author":[{"given":"Su Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin Ae","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Kyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang Je","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Hoon","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na Gyong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,21]]},"reference":[{"key":"2121_CR1","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/j.vaccine.2007.01.111","volume":"25","author":"J. C. Aguilar","year":"2007","unstructured":"Aguilar, J. C. and Rodriguez, E. G., Vaccine adjuvants revisited. Vaccine, 25, 3752\u20133762 (2007).","journal-title":"Vaccine"},{"key":"2121_CR2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0171-2985(11)80355-4","volume":"187","author":"C. R. Alving","year":"1993","unstructured":"Alving, C. R., Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Immunobiology, 187, 430\u2013446 (1993).","journal-title":"Immunobiology"},{"key":"2121_CR3","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1016\/j.vaccine.2006.04.048","volume":"24","author":"Y. J. Cho","year":"2006","unstructured":"Cho, Y. J., Ahn, B. Y., Lee, N. G., Lee, D. H., and Kim, D. S., A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy. Vaccine, 24, 5862\u20135871 (2006).","journal-title":"Vaccine"},{"key":"2121_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1348-0421.2007.tb03903.x","volume":"51","author":"Y. J. Cho","year":"2007","unstructured":"Cho, Y. J., Ahn, B. Y., Song, E. S., Park, S. A., Lee, D. H., Kim, D. S., and Lee, N. G., Bacterial DNA containing methylated CpG motifs retains immunostimulatory activity in synergy with modified lipopolysaccharides. Microbiol. Immunol., 51, 211\u2013222 (2007).","journal-title":"Microbiol. Immunol."},{"key":"2121_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","volume":"19","author":"R. J. Collier","year":"2003","unstructured":"Collier, R. J. and Young, J. A., Anthrax toxin. Annu. Rev. Cell Dev. Biol., 19, 45\u201370 (2003).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"2121_CR6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10875-004-6244-3","volume":"24","author":"C. L. Cooper","year":"2004","unstructured":"Cooper, C. L., Davis, H. L., Morris, M. L., Efler, S. M., Adhami, M. A., Krieg, A. M., Cameron, D. W., and Heathcote, J., CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I\/II study. J. Clin. Immunol., 24, 693\u2013701 (2004).","journal-title":"J. Clin. Immunol."},{"key":"2121_CR7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4049\/jimmunol.109.2.394","volume":"109","author":"R. Pauli Di","year":"1972","unstructured":"Di Pauli, R., Genetics of the immune response. I. Differences in the specificity of antibodies to lipopolysaccharides among different strains of mice. J. Immunol., 109, 394\u2013400 (1972).","journal-title":"J. Immunol."},{"key":"2121_CR8","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.4049\/jimmunol.166.11.6855","volume":"166","author":"J. J. Gao","year":"2001","unstructured":"Gao, J. J., Xue, Q., Papasian, C. J., and Morrison, D. C., Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-alpha through a post-transcriptional mechanism. J. Immunol., 166, 6855\u20136860 (2001).","journal-title":"J. Immunol."},{"key":"2121_CR9","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1016\/j.vaccine.2006.06.005","volume":"24","author":"S. L. Giannini","year":"2006","unstructured":"Giannini, S. L., Hanon, E., Moris, P., Van Mechelen, M., Morel, S., Dessy, F., Fourneau, M. A., Colau, B., Suzich, J., Losonksy, G., Martin, M. T., Dubin, G., and Wettendorff, M. A., Enhanced humoral and memory B cellular immunity using HPV16\/18 L1 VLP vaccine formulated with the MPL\/aluminium salt combination (AS04) compared to aluminium salt only. Vaccine, 24, 5937\u20135949 (2006).","journal-title":"Vaccine"},{"key":"2121_CR10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.vaccine.2006.07.056","volume":"25","author":"M. Gu","year":"2007","unstructured":"Gu, M., Hine, P. M., James Jackson, W., Giri, L., and Nabors, G. S., Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109. Vaccine, 25, 526\u2013534 (2007).","journal-title":"Vaccine"},{"key":"2121_CR11","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2003.12.020","volume":"22","author":"D. M. Klinman","year":"2004","unstructured":"Klinman, D. M., Xie, H., Little, S. F., Currie, D., and Ivins, B. E., CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques. Vaccine, 22, 2881\u20132886 (2004).","journal-title":"Vaccine"},{"key":"2121_CR12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.ki.5002725","volume":"73","author":"N. C. Kong","year":"2008","unstructured":"Kong, N. C., Beran, J., Kee, S. A., Miguel, J. L., S\u00e1nchez, C., Bayas, J. M., Vilella, A., Calbo-Torrecillas, F., L\u00f3pez de Novales, E., Srinivasa, K., Stoffel, M., and Hoet, B., A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int., 73, 856\u2013862(2008).","journal-title":"Kidney Int."},{"key":"2121_CR13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","volume":"22","author":"S. F. Little","year":"2004","unstructured":"Little, S. F., Ivins, B. E., Fellows, P. F., Pitt, M. L., Norris, S. L., and Andrews, G. P., Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine, 22, 422\u2013430 (2004).","journal-title":"Vaccine"},{"key":"2121_CR14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","volume":"55","author":"M. Mock","year":"2001","unstructured":"Mock, M. and Fouet, A., Anthrax. Annu. Rev. Microbiol., 55, 647\u2013671 (2001).","journal-title":"Annu. Rev. Microbiol."},{"key":"2121_CR15","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/0959-8049(96)00186-4","volume":"32A","author":"F. Otto","year":"1996","unstructured":"Otto, F., Schmid, P., Mackensen, A., Wehr, U., Seiz, A., Braun, M., Galanos, C., Mertelsmann, R., and Engelhardt, R., Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer. Eur. J. Cancer, 32A, 1712\u20131718 (1996).","journal-title":"Eur. J. Cancer"},{"key":"2121_CR16","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/IAI.01722-07","volume":"76","author":"Y. S. Park","year":"2008","unstructured":"Park, Y. S., Lee, J. H., Hung, C. F., Wu, T. C., and Kim, T. W., Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant. Infect. Immun., 76, 1952\u20131959 (2008).","journal-title":"Infect. Immun."},{"key":"2121_CR17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1348-0421.2007.tb04005.x","volume":"51","author":"S. A. Park","year":"2007","unstructured":"Park, S. A., Song, E. S., Cho, Y. J., Ahn, B. Y., Ha, S. H., Seong, B. L., Lee, K. H., and Lee, N. G., Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant. Microbiol. Immunol., 51, 1099\u20131107 (2007).","journal-title":"Microbiol. Immunol."},{"key":"2121_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-1759(00)00320-3","volume":"247","author":"S. Pichyangkul","year":"2001","unstructured":"Pichyangkul, S., Yongvanitchit, K., Kum-arb, U., Krieg, A. M., Heppner, D. G., and Wals, D. S., Whole blood cultures to assess the immunostimulatory activities of CpG oligodeoxynucleotides. J. Immunol. Methods, 247, 83\u201394 (2001).","journal-title":"J. Immunol. Methods"},{"key":"2121_CR19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0264-410X(01)00387-5","volume":"20","author":"P. R. Pittman","year":"2001","unstructured":"Pittman, P. R., Gibbs, P. H., Cannon, T. L., and Friedlander, A. M., Anthrax vaccine: short-term safety experience in humans. Vaccine, 20, 972\u2013978 (2001).","journal-title":"Vaccine"},{"key":"2121_CR20","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","volume":"20","author":"P. R. Pittman","year":"2002","unstructured":"Pittman, P. R., Kim-Ahn, G., Pifat, D. Y., Coonan, K., Gibbs, P., Little, S., Pace-Templeton, J. G., Myers, R., Parker, G. W., and Friedlander, A. M., Anthrax vaccine: immunogenicity and safety of a dose-reduction, route change comparison study in humans. Vaccine, 20, 1412\u20131420 (2002).","journal-title":"Vaccine"},{"key":"2121_CR21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nm0204-112b","volume":"10","author":"T. Ready","year":"2004","unstructured":"Ready, T., US soldiers refuse to fall in line with anthrax vaccination scheme. Nat. Med., 10, 112 (2004).","journal-title":"Nat. Med."},{"key":"2121_CR22","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","volume":"100","author":"G. E. Rhie","year":"2003","unstructured":"Rhie, G. E., Roehrl, M. H., Mourez, M., Collier, R. J., Mekalanos, J. J., and Wang, J. Y., A dually active anthrax vaccine that confers protection against both bacilli and toxins. Proc. Natl. Acad. Sci. USA, 100, 10925\u201310930 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2121_CR23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1574-695X.2007.00325.x","volume":"51","author":"E. S. Song","year":"2007","unstructured":"Song, E. S., Park, S. A., Kim, S. H., Cho, Y. J., Ahn, B. Y., Ahn, B. C., and Lee, N. G., Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen. FEMS Immunol. Med. Microbiol., 51, 496\u2013504 (2007).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"2121_CR24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00001432-200004000-00004","volume":"13","author":"P. C. Turnbull","year":"2000","unstructured":"Turnbull, P. C., Current status of immunization against anthrax: old vaccines may be here to stay for a while. Curr. Opin. Infect. Dis., 13, 113\u2013120 (2000).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"2121_CR25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-9433-4-4","volume":"4","author":"J. Y. Wang","year":"2005","unstructured":"Wang, J. Y. and Roehrl, M. H., Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin. Med. Immunol., 4, 4\u201311 (2005).","journal-title":"Med. Immunol."},{"key":"2121_CR26","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/IAI.73.2.828-833.2005","volume":"73","author":"H. Xie","year":"2005","unstructured":"Xie, H., Gursel, I., Ivins, B. E., Singh, M., O\u2019Hagan, D. T., Ulmer, J. B., and Klinman, D. M., CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine. Infect. Immun., 73, 828\u2013833 (2005).","journal-title":"Infect. Immun."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-001-2121-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-001-2121-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-001-2121-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T06:35:07Z","timestamp":1684650907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-001-2121-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1007\/s12272-001-2121-2","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}